Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ $227.25)
- $227.25 P/E (TTM): 21.94X Cap: $547.51B
- View JNJ Profile
- View Questions on JNJ

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $504.22)
- $504.22 P/E (TTM): 66.61X Cap: $178.74B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $469.90)
- $469.90 P/E (TTM): 33.26X Cap: $119.22B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $223.01)
- $223.01 P/E (TTM): 170.24X Cap: $394.14B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $227.25)
- $227.25 P/E (TTM): 21.94X Cap: $547.51B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,037.15)
- $1,037.15 P/E (TTM): 50.1X Cap: $980.50B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $110.27)
- $110.27 P/E (TTM): 14.32X Cap: $273.69B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $172.43)
- $172.43 P/E (TTM): 20.63X Cap: $8.51B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $670.46)
- $670.46 P/E (TTM): 53.66X Cap: $53.53B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $71.71)
- $71.71 P/E (TTM): 15.1X Cap: $8.43B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $100.07)
- $100.07 P/E (TTM): 17.11X Cap: $19.64B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $24.30)
- $24.30 P/E (TTM): 14.29X Cap: $2.98B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $28.99)
- $28.99 P/E (TTM): 367.68X Cap: $239.83B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

Johnson & Johnson (JNJ $227.25)
- $227.25 P/E (TTM): 21.94X Cap: $547.51B
- View JNJ Profile
- View Questions on JNJ
Procter & Gamble Company (The) (PG $151.77)
- $151.77 P/E (TTM): 21.88X Cap: $352.71B
- View PG Profile
- View Questions on PG

Q: trying to decide between these two companies. PG does seem to have negative momentum. Is there more upside in PG or do you prefer JNJ or equal amounts of both?

Thanks Dave

Read Answer Asked by Dave on December 02, 2025

Amgen Inc. (AMGN $341.88)
- $341.88 P/E (TTM): 26.48X Cap: $184.09B
- View AMGN Profile
- View Questions on AMGN
CVS Health Corporation (CVS $74.52)
- $74.52 P/E (TTM): 196.11X Cap: $94.59B
- View CVS Profile
- View Questions on CVS
Johnson & Johnson (JNJ $227.25)
- $227.25 P/E (TTM): 21.94X Cap: $547.51B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $102.96)
- $102.96 P/E (TTM): 27.3X Cap: $131.99B
- View MDT Profile
- View Questions on MDT
Moderna Inc. (MRNA $44.07)
- $44.07 Cap: $17.21B
- View MRNA Profile
- View Questions on MRNA

Q: I am building a diversified portfolio of healthcare stocks. I own JNJ, AMGN, MDT, CVS and MRNA. These are 2.9%, 3.8%, 2.5%, 4% and 0.5% of my portfolio respectively. Is this a high quality portfolio? Would you recommend any changes?

Read Answer Asked by David on October 08, 2025